Exact Mass: 918.3542

Exact Mass Matches: 918.3542

Found 23 metabolites which its exact mass value is equals to given mass value 918.3542, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Amanitin

Alpha-Amanitine

C39H54N10O14S (918.3542)

D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins D009676 - Noxae > D011042 - Poisons > D000546 - Amanitins

alpha-amanitin

2-[34-(Butan-2-yl)-13-(3,4-dihydroxybutan-2-yl)-2,8,11,14,22,30,33,36,39-nonahydroxy-5,27-dioxo-27-thia-3,6,12,15,25,29,32,35,38-nonaazapentacyclo[14.12.11.0,.0,.0,]nonatriaconta-2,11,14,18(26),19(24),20,22,29,32,35,38-undecaen-4-yl]ethanimidate

C39H54N10O14S (918.3542)

D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins D009676 - Noxae > D011042 - Poisons > D000546 - Amanitins

RA-XII

10-[(4-methoxyphenyl)methyl]-4,7,9,13,15,29-hexamethyl-24-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-22-oxa-3,6,9,12,15,29-hexazatetracyclo[14.12.2.218,21.123,27]tritriaconta-18,20,23,25,27(31),32-hexaene-2,5,8,11,14,30-hexone

C46H58N6O14 (918.4011)

alpha-Amanitin

C39H54N10O14S (918.3542)

A heterodetic cyclic peptide consisting of eight amino acid residues and containing a thioether bridge between a cysteine and a tryptophan residue. It is found in a number of poisonous mushrooms, including Amanita phalloides (the death cap), Galerina marginata, and and Conocybe filaris.

rubiyunnanin B

C46H58N6O14 (918.4011)

4-O-[6-O-(5-O-sinapoyl-beta-D-apiofuranosyl)-beta-D-glucopyranosyl]-(+)-(7S,7S,8R,8R)-4-hydroxy-3,3,5,5-tetramethoxy-7,9:7,9-diepoxylignane|obtusifoside C

C44H54O21 (918.3157)

C46H58N6O14_(1S,4R,7S,10S,13S,16S)-10-(4-Methoxybenzyl)-4,7,9,13,15,29-hexamethyl-2,5,8,11,14,30-hexaoxo-22-oxa-3,6,9,12,15,29-hexaazatetracyclo[14.12.2.2~18,21~.1~23,27~]tritriaconta-18,20,23(31),24,26,32-hexaen-24-yl beta-D-glucopyranoside

NCGC00384826-01_C46H58N6O14_(1S,4R,7S,10S,13S,16S)-10-(4-Methoxybenzyl)-4,7,9,13,15,29-hexamethyl-2,5,8,11,14,30-hexaoxo-22-oxa-3,6,9,12,15,29-hexaazatetracyclo[14.12.2.2~18,21~.1~23,27~]tritriaconta-18,20,23(31),24,26,32-hexaen-24-yl beta-D-glucopyranoside

C46H58N6O14 (918.4011)

10-[(4-methoxyphenyl)methyl]-4,7,9,13,15,29-hexamethyl-24-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-22-oxa-3,6,9,12,15,29-hexaazatetracyclo[14.12.2.2¹⁸,²¹.1²³,²⁷]tritriaconta-18,20,23(31),24,26,32-hexaene-2,5,8,11,14,30-hexone

10-[(4-methoxyphenyl)methyl]-4,7,9,13,15,29-hexamethyl-24-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-22-oxa-3,6,9,12,15,29-hexaazatetracyclo[14.12.2.2¹⁸,²¹.1²³,²⁷]tritriaconta-18,20,23(31),24,26,32-hexaene-2,5,8,11,14,30-hexone

C46H58N6O14 (918.4011)

dibutyl[[3-[[dibutyl[[2-[(octyloxy)carbonyl]ethyl]thio]stannyl]thio]propionyl]oxy](octyloxy)stannane

C38H78O5S2Sn2 (918.3334)

ferroheme aS

C54H62FeN4O6-4 (918.4019)

(8beta)-1-O-benzoyl-1-O-2-O-dideacetyl-8-deoxo-2-O-[(1,6-dihydro-1-methyl-6-oxo-3-pyridinyl)carbonyl]-8-hydroxyevonine

C46H50N2O18 (918.3058)

alpha-Neup5Ac-(2->6)-beta-D-GlcpNAc-(1->4)-beta-D-GlcpNAc-(1->4)-D-GlcpNAc

C35H58N4O24 (918.3441)

alpha-Amatoxin

C39H54N10O14S (918.3542)

D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins D009676 - Noxae > D011042 - Poisons > D000546 - Amanitins

emarginatine F

C46H50N2O18 (918.3058)

A sesquiterpene alkaloid that is a macrolide incorporating a substituted dihydroagarofuran and a pyrindine ring. Isolated from Maytenus emarginata, it exhibits strong cytotoxicity against human epidermoid carcinoma of the nasopharynx (KB), ileocecal adenocarcinoma (HCT-8), melanoma (RPMI-7951) and medulloblastoma (TE-671) tumor cells, and against murine leukemia (P-388).

LPIM2 18:3

C39H67O22P (918.3861)

(1s,4r,10r,13r,16r,34r)-13-(3,4-dihydroxybutan-2-yl)-2,8,11,14,22,30,33,36,39-nonahydroxy-4-(c-hydroxycarbonimidoylmethyl)-5-oxo-34-(sec-butyl)-27-thia-3,6,12,15,25,29,32,35,38-nonaazapentacyclo[14.12.11.0⁶,¹⁰.0¹⁸,²⁶.0¹⁹,²⁴]nonatriaconta-2,11,14,18(26),19,21,23,29,32,35,38-undecaen-27-ium-27-olate

(1s,4r,10r,13r,16r,34r)-13-(3,4-dihydroxybutan-2-yl)-2,8,11,14,22,30,33,36,39-nonahydroxy-4-(c-hydroxycarbonimidoylmethyl)-5-oxo-34-(sec-butyl)-27-thia-3,6,12,15,25,29,32,35,38-nonaazapentacyclo[14.12.11.0⁶,¹⁰.0¹⁸,²⁶.0¹⁹,²⁴]nonatriaconta-2,11,14,18(26),19,21,23,29,32,35,38-undecaen-27-ium-27-olate

C39H54N10O14S (918.3542)

21,24-bis(acetyloxy)-20-[(acetyloxy)methyl]-19-(benzoyloxy)-22,25-dihydroxy-3,13,14,25-tetramethyl-6,15-dioxo-2,5,16-trioxa-11-azapentacyclo[15.7.1.0¹,²⁰.0³,²³.0⁷,¹²]pentacosa-7,9,11-trien-18-yl 1-methyl-6-oxopyridine-3-carboxylate

21,24-bis(acetyloxy)-20-[(acetyloxy)methyl]-19-(benzoyloxy)-22,25-dihydroxy-3,13,14,25-tetramethyl-6,15-dioxo-2,5,16-trioxa-11-azapentacyclo[15.7.1.0¹,²⁰.0³,²³.0⁷,¹²]pentacosa-7,9,11-trien-18-yl 1-methyl-6-oxopyridine-3-carboxylate

C46H50N2O18 (918.3058)

(1s,4r,7s,10s,13s,16s)-2,5,11-trihydroxy-10-[(4-methoxyphenyl)methyl]-4,7,9,13,15,29-hexamethyl-24-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-22-oxa-3,6,9,12,15,29-hexaazatetracyclo[14.12.2.2¹⁸,²¹.1²³,²⁷]tritriaconta-2,5,11,18,20,23(31),24,26,32-nonaene-8,14,30-trione

(1s,4r,7s,10s,13s,16s)-2,5,11-trihydroxy-10-[(4-methoxyphenyl)methyl]-4,7,9,13,15,29-hexamethyl-24-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-22-oxa-3,6,9,12,15,29-hexaazatetracyclo[14.12.2.2¹⁸,²¹.1²³,²⁷]tritriaconta-2,5,11,18,20,23(31),24,26,32-nonaene-8,14,30-trione

C46H58N6O14 (918.4011)

13-(3,4-dihydroxybutan-2-yl)-2,8,11,14,22,30,33,36,39-nonahydroxy-4-(c-hydroxycarbonimidoylmethyl)-5-oxo-34-(sec-butyl)-27-thia-3,6,12,15,25,29,32,35,38-nonaazapentacyclo[14.12.11.0⁶,¹⁰.0¹⁸,²⁶.0¹⁹,²⁴]nonatriaconta-2,11,14,18(26),19,21,23,29,32,35,38-undecaen-27-ium-27-olate

13-(3,4-dihydroxybutan-2-yl)-2,8,11,14,22,30,33,36,39-nonahydroxy-4-(c-hydroxycarbonimidoylmethyl)-5-oxo-34-(sec-butyl)-27-thia-3,6,12,15,25,29,32,35,38-nonaazapentacyclo[14.12.11.0⁶,¹⁰.0¹⁸,²⁶.0¹⁹,²⁴]nonatriaconta-2,11,14,18(26),19,21,23,29,32,35,38-undecaen-27-ium-27-olate

C39H54N10O14S (918.3542)

(1s,4r,7s,10s,13s,16s)-2,5,11,31-tetrahydroxy-10-[(4-methoxyphenyl)methyl]-4,7,9,13,15,28-hexamethyl-23-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,6,9,12,15,28-hexaazatetracyclo[14.11.2.2¹⁸,²¹.1²²,²⁶]dotriaconta-2,5,11,18,20,22(30),23,25,31-nonaene-8,14,29-trione

(1s,4r,7s,10s,13s,16s)-2,5,11,31-tetrahydroxy-10-[(4-methoxyphenyl)methyl]-4,7,9,13,15,28-hexamethyl-23-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,6,9,12,15,28-hexaazatetracyclo[14.11.2.2¹⁸,²¹.1²²,²⁶]dotriaconta-2,5,11,18,20,22(30),23,25,31-nonaene-8,14,29-trione

C46H58N6O14 (918.4011)

2,5,11-trihydroxy-10-[(4-methoxyphenyl)methyl]-4,7,9,13,15,29-hexamethyl-24-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-22-oxa-3,6,9,12,15,29-hexaazatetracyclo[14.12.2.2¹⁸,²¹.1²³,²⁷]tritriaconta-2,5,11,18,20,23(31),24,26,32-nonaene-8,14,30-trione

2,5,11-trihydroxy-10-[(4-methoxyphenyl)methyl]-4,7,9,13,15,29-hexamethyl-24-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-22-oxa-3,6,9,12,15,29-hexaazatetracyclo[14.12.2.2¹⁸,²¹.1²³,²⁷]tritriaconta-2,5,11,18,20,23(31),24,26,32-nonaene-8,14,30-trione

C46H58N6O14 (918.4011)

2,5,11,31-tetrahydroxy-10-[(4-methoxyphenyl)methyl]-4,7,9,13,15,28-hexamethyl-23-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,6,9,12,15,28-hexaazatetracyclo[14.11.2.2¹⁸,²¹.1²²,²⁶]dotriaconta-2,5,11,18,20,22(30),23,25,31-nonaene-8,14,29-trione

2,5,11,31-tetrahydroxy-10-[(4-methoxyphenyl)methyl]-4,7,9,13,15,28-hexamethyl-23-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,6,9,12,15,28-hexaazatetracyclo[14.11.2.2¹⁸,²¹.1²²,²⁶]dotriaconta-2,5,11,18,20,22(30),23,25,31-nonaene-8,14,29-trione

C46H58N6O14 (918.4011)

PIP2(O-30:5)

C39H69O18P3 (918.3697)